150 related articles for article (PubMed ID: 871029)
1. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks.
Steele P; Carroll J; Overfield D; Genton E
Stroke; 1977; 8(3):396-8. PubMed ID: 871029
[TBL] [Abstract][Full Text] [Related]
2. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
Steele P; Battock D; Genton E
Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247
[TBL] [Abstract][Full Text] [Related]
3. Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time.
Steele P; Rainwater J; Vogel R
Circulation; 1979 Oct; 60(4):910-3. PubMed ID: 476893
[TBL] [Abstract][Full Text] [Related]
4. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
Robertson JT; Dugdale M; Salky N; Robinson H
Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880
[No Abstract] [Full Text] [Related]
5. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
Friedman LM
Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
[TBL] [Abstract][Full Text] [Related]
6. Platelet survival time and thromboembolism in patients with mitral valve prolapse.
Steele P; Weily H; Rainwater J; Vogel R
Circulation; 1979 Jul; 60(1):43-5. PubMed ID: 445732
[TBL] [Abstract][Full Text] [Related]
7. Platelet-suppressant therapy in patients with coronary artery disease.
Steele P; Rainwater J; Vogel R; Genton E
JAMA; 1978 Jul; 240(3):228-31. PubMed ID: 307069
[TBL] [Abstract][Full Text] [Related]
8. Does platelet antiaggregant therapy lessen the severity of stroke?
Grotta JC; Lemak NA; Gary H; Fields WS; Vital D
Neurology; 1985 May; 35(5):632-6. PubMed ID: 3887210
[TBL] [Abstract][Full Text] [Related]
9. The role of platelets in transient ischemic attacks and cerebral vascular accidents.
Barnett HJ
Adv Exp Med Biol; 1978; 102():257-63. PubMed ID: 685753
[TBL] [Abstract][Full Text] [Related]
10. [Antiplatelet drugs (author's transl)].
Dechavanne M; Follea G; Trzeciak MC
Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
[TBL] [Abstract][Full Text] [Related]
11. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
[TBL] [Abstract][Full Text] [Related]
12. Increased platelet aggregates in patients with transient ischemic attacks.
Wu KK; Hoak JC
Stroke; 1975; 6(5):521-4. PubMed ID: 1179461
[TBL] [Abstract][Full Text] [Related]
13. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Oelz O
Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
[TBL] [Abstract][Full Text] [Related]
14. Platelet and antiplatelet agents in strokes.
Rodvien R; Mielke CH
Stroke; 1978; 9(4):403-5. PubMed ID: 675751
[No Abstract] [Full Text] [Related]
15. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
Canadian Cooperative Study Group
N Engl J Med; 1978 Jul; 299(2):53-9. PubMed ID: 351394
[TBL] [Abstract][Full Text] [Related]
16. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Genton E
Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
[No Abstract] [Full Text] [Related]
17. Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
Genton E; Ellis J; Steele P
Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198422
[No Abstract] [Full Text] [Related]
18. Platelet inhibition in the management of thrombosis.
Didisheim P; Kazmier FJ; Fuster V
Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: The effect of sulphinpyrazone (Anturan) on immunologically derived thrombocytopenia and on platelet survival.
White AM; Butler KD
Thromb Diath Haemorrh; 1975 Nov; 34(2):553-4. PubMed ID: 128152
[No Abstract] [Full Text] [Related]
20. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
